scispace - formally typeset
A

Asma B. M. Buanz

Researcher at University College London

Publications -  43
Citations -  3026

Asma B. M. Buanz is an academic researcher from University College London. The author has contributed to research in topics: Controlled release & Differential scanning calorimetry. The author has an hindex of 17, co-authored 37 publications receiving 2425 citations. Previous affiliations of Asma B. M. Buanz include University of London.

Papers
More filters
Journal ArticleDOI

Effect of geometry on drug release from 3D printed tablets.

TL;DR: This work has demonstrated the potential of 3DP to manufacture tablet shapes of different geometries, many of which would be challenging to manufacture by powder compaction.
Journal ArticleDOI

Fused-filament 3D printing (3DP) for fabrication of tablets.

TL;DR: The study indicates that FF 3DP has the potential to offer a new solution for fabricating personalized-dose medicines or unit dosage forms with controlled-release profiles and the low cost of FDM printers means the paradigm of extemporaneous or point-of-use manufacture of personalized- dose tablets is both feasible and attainable.
Journal ArticleDOI

3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets

TL;DR: The potential role of FDM 3DP as an efficient and low-cost alternative method of manufacturing individually tailored oral drug dosage, and also for production of modified-release formulations, is demonstrated.
Journal ArticleDOI

3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics

TL;DR: The study confirms the potential of 3D printing to fabricate multiple-drug containing devices with specialized design configurations and unique drug release characteristics, which would not otherwise be possible using conventional manufacturing methods.
Journal ArticleDOI

Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing

TL;DR: The potential of combining FDM 3D printing technology with established pharmaceutical processes, including HME and film coating, to fabricate modified release oral dosage forms has been demonstrated.